When Is a Virus Contagious and How Does It Spread?

A virus typically becomes contagious before, during, or shortly after it begins replicating fast enough to shed from the body in quantities that can infect someone else. For many respiratory viruses, that window opens before symptoms appear and closes days to weeks later, depending on the pathogen and the person’s immune response. The routes of spread vary just as widely, from inhaled aerosols and contaminated surfaces to insect bites and fecal contamination. Understanding when and how a virus spreads matters because the answers are often counterintuitive, and the details differ enough between viruses that a one-size-fits-all rule can be genuinely misleading.

The Contagious Window Often Opens Before You Feel Sick

One of the most important things to understand about viral contagiousness is the gap between when a person becomes infectious and when symptoms show up. Viruses replicate inside host cells during what’s called the latent period (the time from infection to when a person starts shedding virus). The incubation period, by contrast, is the time from infection to symptom onset. When the latent period is shorter than the incubation period, a person is shedding virus and potentially spreading it to others while still feeling perfectly fine.

This was a defining challenge during the COVID-19 pandemic. A modeling study estimated that roughly 59% of all SARS-CoV-2 transmission came from people who were not showing symptoms at the time they spread the virus: about 35% from people who were presymptomatic (they would develop symptoms later) and about 24% from people who never developed symptoms at all.¹ That means the majority of spread happened invisibly, which is why symptom-based screening alone was never sufficient to contain the virus.

The size of that presymptomatic window depends on the specific pathogen and even the variant. For SARS-CoV-2’s Omicron variant, the average latent period was about 2.65 days while the average incubation period was about 3.4 days, leaving roughly a day of contagiousness before symptoms began.² For the Delta variant, those numbers were longer: a mean latent period around 4.3 days and incubation period around 5 days.³ Either way, every variant left a window where people were contagious before they knew they were infected.

Not every virus works this way. With the original SARS coronavirus (SARS-CoV-1), viral shedding peaked well after symptom onset, around days 10 to 14 of illness, which made isolating symptomatic patients an effective containment tool.⁴ MERS-CoV peaked somewhat later too, around days 7 to 10. Influenza also sheds before symptoms, but the window is narrower, and viral load tends to peak around the second day of symptoms.⁵

Viral Load and When It Peaks

The amount of virus in a person’s body at any given moment, the viral load, is the single best predictor of how contagious they are on a given day. For SARS-CoV-2, a pooled analysis of dozens of studies found that viral load in the upper respiratory tract peaked before or right around symptom onset, then stayed elevated for up to three weeks, though at declining levels.⁶ With later Omicron-era variants, peak viral load shifted slightly, with measurements showing it cresting around the fourth day after symptoms appeared.⁵

An important wrinkle here is that detecting viral genetic material on a test does not necessarily mean a person is still infectious. PCR tests can pick up fragments of viral RNA for weeks after infection, long past the point where the person can actually transmit live virus.⁷ The distinction between shedding detectable RNA and shedding enough live, replication-competent virus to infect someone else is crucial, and it’s one reason why prolonged positive test results don’t necessarily mean prolonged contagiousness.

Do People Without Symptoms Carry the Same Amount of Virus?

A common question is whether people who never develop symptoms carry less virus and are therefore less dangerous. The answer from multiple studies is surprisingly clear: at the point of testing, asymptomatic and symptomatic adults often carry similar amounts of virus. A systematic review and meta-analysis of COVID-19 studies found no significant difference in viral load between symptomatic and asymptomatic people when measured by the key gene targets used in PCR testing.⁸ A study during the Omicron wave found comparable nasopharyngeal viral loads in both groups as well.⁹

The picture may differ for children, though. A pediatric hospital study found that asymptomatic children had meaningfully lower viral loads than symptomatic children, though the authors cautioned that timing of infection relative to testing likely played a role.¹⁰ It’s possible that asymptomatic children were simply caught at a different phase of infection rather than fundamentally carrying less virus throughout.

How Respiratory Viruses Travel Through the Air

The traditional explanation of respiratory virus transmission divided the world neatly into “droplets” (large particles that fall to the ground within a couple of meters) and “airborne” particles (tiny enough to float for hours). The COVID-19 pandemic forced a serious rethinking of that framework. A major review in Science argued that the old definitions don’t capture how virus-laden particles actually behave in indoor air. Respiratory emissions exist on a continuous spectrum of sizes, and even particles once classified as “droplets” can linger in the air longer than previously assumed, especially in poorly ventilated rooms.¹¹

What you do with your voice matters more than you might expect. A study measuring particle emissions during speech found that the number of particles released increased linearly with how loudly a person spoke, jumping from about 6 particles per second at a whisper to 53 per second at a near-shout, with particle size staying roughly the same regardless of volume.¹² A clinical study of COVID-19 patients found that 94% of detected SARS-CoV-2 RNA in the air around them was produced during talking and singing rather than quiet breathing.¹³ This helps explain why crowded, noisy indoor gatherings like bars, choir rehearsals, and nightclubs were consistent sites of early superspreading events.

Other Routes of Spread

Not all viruses travel through the air. The fecal-oral route is the main highway for norovirus, rotavirus, hepatitis A, and many other enteric pathogens. These viruses are shed in stool, survive in the environment, and enter a new host through contaminated food, water, or surfaces. Research has shown that rotavirus particles travel in the gut enclosed within tiny membrane-bound vesicles, each carrying clusters of ten or more viral particles. These vesicle-wrapped clusters are themselves infectious units and appear to be more efficiently transmitted than single free-floating viruses.¹⁴

Vector-borne viruses rely on a living intermediary, usually a mosquito or tick, to move between hosts. Dengue, Zika, and chikungunya are all carried by Aedes mosquitoes. The mosquito’s own biology matters: laboratory work has demonstrated that certain insect-specific viruses already present in mosquitoes can enhance their ability to transmit dengue and Zika to a vertebrate host.¹⁵ And while mosquitoes are the primary route for dengue, rare cases of person-to-person transmission have been documented, including at least one case through mucocutaneous exposure to infected blood in a healthcare setting.¹⁶

Surface (fomite) transmission also depends on the type of virus. A general pattern is that viruses with a lipid envelope, like influenza and coronaviruses, tend to be more fragile on surfaces, persisting for less than five days under typical conditions. Non-enveloped viruses, like norovirus, are far tougher and can survive on surfaces for weeks.¹⁷ The envelope’s lipid layer, while useful for entering cells, makes these viruses more vulnerable to drying, detergents, and heat. Studies comparing decay rates on fabrics have confirmed that enveloped viruses lose infectivity substantially faster than non-enveloped ones under the same conditions.¹⁸

Why Some Infections Spread More Easily Than Others

The infectious dose, the number of viral particles needed to actually establish an infection, varies enormously from one virus to another. For several major respiratory viruses, including influenza, rhinovirus, and adenovirus, the dose required to infect half of exposed people can be startlingly small, sometimes less than one tissue-culture infectious unit. Many enteric viruses like norovirus, rotavirus, and hepatitis A also require very low doses.¹⁹ This is part of why norovirus is famously hard to contain: it takes almost nothing to start a new infection.

But individual encounters still produce wildly uneven outcomes. Modeling work on SARS-CoV-2 showed that superspreading events required a combination of high viral load (above roughly 10 million RNA copies) and a high number of close contacts on the same day. Below that viral-load threshold, even heavy social contact produced limited transmission. Above it, each additional contact disproportionately increased the number of new infections.²⁰ In other words, superspreading isn’t just about a person being highly infectious. It’s the collision of peak viral load with peak social exposure.

Temperature, Humidity, and Ventilation

Environmental conditions play a measurable role in how long viruses remain infectious outside the body and how efficiently they transmit. For influenza, temperature is one of the strongest predictors of how long the virus persists in air, water, and on surfaces. Higher temperatures consistently shorten the virus’s half-life.²¹

Humidity’s effect is less straightforward. Studies on coronaviruses found that at 4°C, infectious virus persisted on surfaces for up to 28 days. At 20°C, survival dropped but was still measured in days to weeks. And while you might expect higher humidity to always be worse, the relationship isn’t simple: coronaviruses actually survived longest at low humidity (around 20%) and at high humidity (around 80%), with moderate humidity (around 50%) producing the fastest inactivation.²² This U-shaped curve helps explain why both dry winter air and humid tropical conditions can each favor virus survival, though through different mechanisms.

Indoor ventilation is one of the most practical levers available for reducing airborne transmission. A systematic review of ventilation strategies in classrooms found that both natural ventilation (opening windows, designing buildings for airflow) and mechanical systems can meaningfully reduce the concentration of airborne pathogens indoors. Strategies like controlling ventilation based on carbon dioxide levels or infection-risk models were highlighted as effective approaches, particularly during pandemic conditions.²³ Fresh outdoor air dilutes any viral particles floating around, while stagnant indoor air lets them accumulate.

What Rapid Tests Tell You About Contagiousness

PCR tests are extremely sensitive and will detect viral RNA long after a person has stopped being contagious. Rapid antigen tests, on the other hand, are much better at answering the question that actually matters: am I likely to infect someone right now? That’s because antigen tests are most sensitive when viral load is high, which is exactly the window when a person is most contagious.

A large comparison study found that antigen tests predicted the ability to grow live virus (the gold standard for actual infectiousness) with high accuracy. The best-performing antigen assay detected 90% of culture-positive samples, and all tested antigen formats reached at least 95% sensitivity when viral loads exceeded one million genome copies per milliliter.²⁴ Another study found that while rapid antigen tests only caught about 41% of all PCR-positive infections, a negative antigen test had a 99.9% negative predictive value for viral-culture positivity, meaning if your antigen test is negative, you are almost certainly not carrying enough live virus to infect someone.²⁵

Even how quickly the test line appears may carry information. Research found a strong correlation between how fast a rapid antigen test turned positive and the actual viral load. A line appearing within 32 seconds corresponded to very high viral loads with about 95% sensitivity.²⁶ A faint line that takes a while to show up suggests a lower viral load and, probably, lower contagiousness. A dark line appearing almost instantly means a very high viral load and high risk of spreading the virus.

How Antivirals Shorten the Contagious Period

If the contagious window is defined by how long a person sheds enough live virus to infect others, then treatments that speed up viral clearance should shrink that window. A propensity-matched study of over 500 high-risk COVID-19 patients found that early antiviral treatment significantly reduced the duration of viral shedding compared to no treatment, and also lowered the risk of hospitalization and pneumonia.²⁷ The key word there is “early.” Antivirals work by interfering with viral replication, so starting them after the virus has already peaked and the immune system has taken over offers much less benefit. For most respiratory antiviral treatments, the window for meaningful impact is within the first day or two of symptoms.

This creates a practical tension: the period when antivirals would help most is the same period when many people are still figuring out whether they’re actually sick. Rapid testing becomes doubly useful here, both as a signal of contagiousness and as a trigger for treatment decisions.

The Evolutionary Pressure on Transmission

There’s a popular idea that viruses inevitably evolve to become milder over time because killing the host is “bad strategy” for a pathogen that needs to spread. The reality is murkier. Evolutionary theory predicts that pathogens should evolve toward a sweet spot where virulence and transmissibility are balanced. A meta-analysis examining the relationship between virulence and transmission across multiple pathogens found that the overall trend pointed toward more virulent strains transmitting less, but the pattern was not statistically significant and varied widely between systems.²⁸

HIV-1 provides one of the clearest real-world demonstrations. Research using a large, long-running cohort in Uganda found evidence that HIV has been evolving toward lower virulence over time, consistent with the theoretical prediction that intermediate virulence maximizes the virus’s reproductive success in the population.²⁹ But HIV is slow-moving, with years between infection and severe disease. For fast-transmitting respiratory viruses, the calculus is different: a virus that spreads efficiently before causing severe illness faces little evolutionary pressure to become milder, because it has already moved on to new hosts by the time the original host gets seriously ill. The idea that all viruses inevitably mellow out is more comfort narrative than established science.

This matters for understanding pandemic preparedness. A novel respiratory virus that transmits presymptomatically, hangs in the air, and requires a tiny infectious dose can cause enormous population-level harm even if each individual infection is fairly mild. The factors that determine a virus’s contagiousness, from its latent period to the aerosol physics of the rooms we gather in, interact in ways that no single intervention can fully address. Ventilation, testing, vaccination, rapid treatment access, and behavioral awareness each chip away at different parts of the transmission chain.